T-Net23h
Zymeworks Receives US FDA Approval for Ziihera and $25M 'Milestone Payment' From Jazz Pharmaceuticals (Eligible for $1 Billion+)
Embryo-Fetal Toxicity ZIIHERA can cause fetal harm when administered to a pregnant woman. In literature reports, use of a HER2-directed antibody during p ...
T-Net23h
Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled
Lexaria Bioscience Corp., a global innovator in drug delivery platforms announced that dosing has been completed for human pilot study #3 investigating a DehydraTECH-processed version of the dual ...
T-Net23h
D-Wave Names Sharon Holt to Board of Directors
D-Wave Quantum Inc., a leader in quantum computing systems, software, and services and the world's first commercial supplier of quantum computers, announced the appointment of Sharon Holt to its board ...